Dexilant
dexlansoprazole
- Strength
- 60 mg/1
- Form
- Capsule, Delayed Release
- Class
- Proton Pump Inhibitor
Takeda Pharmaceuticals America, Inc.
Listed by A-S Medication Solutions
| Dosage form | Capsule, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Proton Pump Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 50090-7451 |
| FDA application | ANDA202294 |
| RxNorm concept | 833213 |
| Package sizes listed | 2 |
| Marketed since | November 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
dexlansoprazole
Takeda Pharmaceuticals America, Inc.
dexlansoprazole
Takeda Pharmaceuticals America, Inc.
Par Health USA, LLC
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Inc.
Bryant Ranch Prepack
Par Health USA, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.